Related Experiment Video
Updated: Jul 3, 2026
07:26
Isolation of Functional Cardiac Immune Cells
Published on: December 5, 2011
Increased mast cell number in human hypertensive nephropathy
Pia Welker1, Stephanie Krämer, David A Groneberg
1Institute of Anatomy, Charité Universitätsmedizin Berlin, Free University, Berlin, Germany.
American Journal of Physiology. Renal Physiology
|August 8, 2008
Summary
Primary hypertension increases mature mast cells in the kidney, suggesting their role in hypertensive nephropathy. Stem cell factor is also upregulated, indicating early disease changes.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Mast cells are implicated in nonallergic chronic organ damage and fibrosis.
- Understanding mast cell involvement in early hypertensive nephropathy is crucial.
Purpose of the Study:
- To analyze mast cell number, localization, and maturation in hypertensive kidneys.
- To investigate the role of stem cell factor in primary hypertension.
Main Methods:
- Comparative analysis of kidney tissue from hypertensive accident victims and normotensive controls.
- Toluidine blue staining for mast cell enumeration.
- Immunohistological staining for mast cell maturation markers (CD34, IgE receptor, tryptase, chymase) and stem cell factor.
Main Results:
- Hypertensive kidneys showed significantly higher arteriolosclerosis but similar matrix accumulation compared to controls.
- Renal mast cell numbers were fivefold higher in hypertensive subjects, primarily in the peritubular interstitium.
- Mast cells exhibited a mature phenotype, and renal stem cell factor was markedly upregulated in hypertension.
Conclusions:
- Human hypertensive kidney disease exhibits early stem cell factor upregulation and increased mature mast cells.
- Renal mast cell accumulation may contribute to the pathogenesis of hypertensive nephropathy.
Related Concept Videos
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...